Pharmacological inhibition of tyrosine protein-kinase 2 reduces islet inflammation and delays type 1 diabetes onset in mice

Farooq Syed(Indiana University School of Medicine), Carmella Evans‐Molina(Diabetes Australia), Stéphane Demine(Indiana Biosciences Research Institute), Eugenia Martin Vázquez(Université Libre de Bruxelles), Preethi Krishnan(Indiana University – Purdue University Indianapolis), Kara S. Orr(Indiana University – Purdue University Indianapolis), Maria Inês Alvelos(Université Libre de Bruxelles), Ângela Castela(Université Libre de Bruxelles), Alexandra Coomans de Brachène(Université Libre de Bruxelles), Arnaud Zaldumbide(Leiden University Medical Center), Lorella Marselli(University of Pisa), Staci A. Weaver(Indiana University – Purdue University Indianapolis), Décio L. Eizirik(Université Libre de Bruxelles), Sofia Thomaidou, Donalyn Scheuner(Indiana Biosciences Research Institute), John S. Kaddis(City of Hope), Jing Liu(First Affiliated Hospital of Dalian Medical University), Garrick Chang(Indiana University Indianapolis), Jyoti Rana(Indiana University – Purdue University Indianapolis), Olivia Ballew(Indiana Biosciences Research Institute), Namratha Shivani Chalasani(Indiana University School of Medicine), Piero Marchetti, Chih‐Chun Lee(Diabetes Australia), Jamie L. Felton(University School)
EBioMedicine
May 6, 2025
Cited by 14


Related Papers